In the Czech Republic, all HIV-positive patients can be immediately treated after diagnosis, which is key to stopping the epidemic.
In Conversation
As a parallel trade company, we must be compliant in the same manner as other pharma companies, and as a step between the original manufacturers and…
Every time we as a company faced challenges, what encouraged us to keep pushing was the added value we knew we could provide for the Czech…
With the Falsified Medicines Directive of February 9, almost all drugs within the EU had to be serialized to curb the sale of counterfeit drugs.
MD Pál Szamosújvari, Judit Jávor, Pál Szamosújvari Jr—Founder, R&D Director, and Director of Pharma Patent respectively—share their insights on the activities of the company, the importance…
We aim to maintain reasonable growth in our two main business units: we see potential both in the prescription drug segment and the consumer healthcare segment…
I think the country could benefit greatly from streamlining and shortening processes in order to foster a business-friendly environment
In comparison with Western European countries, Hungary has large state hospitals, which facilitates the conduct of clinical trials, while patients get access to treatments that are…
I am at a stage where I have a different perspective, which allows me to conduct R&D in a different way - doing disruptive innovation
Hungary is actually one of the most fortunate countries in Europe for the treatment of diabetes. These products are well reimbursed, and patients have access to…
Janssen's vision for the GCC is to make a greater impact on the healthcare systems by bringing new and innovative medicines to patients
This new facility is currently one of the most modern healthcare infrastructures in Hungary, it will totally increase our efficiency and operational capacity
